Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Quoin Pharmaceuticals Ltd. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Integrated Core Strategies (US) LLC (filed 2026-06-02).
Who is behind it
Quoin Pharmaceuticals Ltd.: business address in Ashburn, Virginia; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-07).
Officers and directors, each with the role and the filing that names them:
- Michael Myers: Executive Officer, Director (Form D, 2026-09-10)
- Sally Bridget Lawlor: Executive Officer (Form D, 2026-09-10)
- Denise Carter: Executive Officer, Director (Form D, 2026-09-10)
- Joseph Cooper: Director (Form D, 2026-09-10)
- James Culverwell: Director (Form D, 2026-09-10)
- Dennis Langer: Director (Form D, 2026-09-10)
- Natalie Leong: Director (Form D, 2026-09-10)
- Michael Sember: Director (Form D, 2026-09-10)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-07 | Ikarian Capital, LLC | 4.4% |
| Schedule 13G, 2026-06-02 | Integrated Core Strategies (US) LLC | 5.5% |
| Schedule 13G/A, 2026-05-15 | Adar1 Capital Management, LLC | 4.9% |
| Schedule 13G/A, 2026-05-15 | Woodline Partners LP | 4.4% |
| Schedule 13G/A, 2026-05-15 | Stonepine Capital Management, LLC | 9.99% |
| Schedule 13G/A, 2026-04-29 | Aberdeen Group PLC | 4.16% |
| Schedule 13G, 2026-02-17 | Woodline Partners LP | 9.5% |
| Schedule 13G, 2026-02-17 | Adar1 Capital Management, LLC | 6.9% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-09-10 | $50M | $50M |
| Form D, 2025-10-23 | $105.25M | $105.25M |
Latest IPO step: Quoin Pharmaceuticals Ltd. filed its final IPO prospectus, ticker QNRX (424B4, 2024-12-23).
IPO filings: 424B4, 2024-12-23, S-1/A, 2024-12-18, S-1, 2024-12-11; ticker QNRX on Nasdaq.
Related pages
Funding and filing history5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/quoin-pharmaceuticals-ltdLast updated 2026-10-18
Primary record: Schedule 13G, 2026-06-02 · Form D, 2026-09-10 · 424B4, 2024-12-23 · S-1/A, 2024-12-18
Who owns Quoin Pharmaceuticals Ltd.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/quoin-pharmaceuticals-ltd